Layer-by-layer gelatin/chondroitin quantum dots-based nanotheranostics: combined rapamycin/celecoxib delivery and cancer imaging. (3rd August 2018)

• Record Type: Journal Article
• Authors: AbdElhamid, Ahmed S; Helmy, Maged W; Ebrahim, Shaker M; Bahey-El-Din, Mohammed; Zayed, Dina G; Zein El Dein, Esmat A; El-Gizawy, Sanaa A; Elzoghby, Ahmed O
• Is Part Of: Nanomedicine. Volume 13:Number 14(2018)
• Publication Date: 2018-08-03
• Subjects: cancer nanotheranostics -- celecoxib -- rapamycin; Nanotechnology -- Periodicals; Medical technology -- Periodicals; Nanotechnology -- Therapeutic use -- Periodicals; 610.28
• DOI: 10.2217/nnm-2018-0028
• Languages: English
• ISSNs: 1743-5889

Abstract

Aim: Nanotheranostics consisting of highly-fluorescent quantum dots coupled with gelatin/chondroitin layer-by-layer assembled nanocapsules were developed.Materials & methods: The hydrophobic drugs celecoxib (CXB) and rapamycin (RAP) were co-loaded into the oily core of nanocapsules (NCs) to enable synergistic growth inhibition of breast cancer cells. To overcome the nonspecific binding of actively targeted CS-NCs with normal cells, a matrix metalloproteinase (MMP-2)-degradable cationic gelatin layer was electrostatically deposited onto the surface of the negatively-charged CS-NCs.Results: The prepared nanocarriers displayed strong fluorescence which enabled tracing their internalization into cancer cells. An enhanced cytotoxicity of the NCs against breast cancer cells was demonstrated. In vivo, the nanoplatforms displayed superior antitumor efficacy as well as nonimmunogenic response.Conclusion: Therefore, these multifunctional nanoplatforms could be used as potential cancer theranostics.